Equities

Hamilton Thorne Ltd

Hamilton Thorne Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CAD)1.36
  • Today's Change-0.03 / -2.16%
  • Shares traded59.20k
  • 1 Year change-19.05%
  • Beta0.2376
Data delayed at least 15 minutes, as of May 08 2024 20:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.

  • Revenue in CAD (TTM)92.25m
  • Net income in CAD-833.01k
  • Incorporated2007
  • Employees--
  • Location
    Hamilton Thorne Ltd100 Cummings Ctr Ste 465eBEVERLY 01915-6143United StatesUSA
  • Phone+1 (978) 921-2050
  • Fax+1 (978) 921-0250
  • Websitehttps://www.hamiltonthorne.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HTL:TOR since
announced
Transaction
value
GYNETICS MEDICAL PRODUCTS NVDeal completed10 Oct 202310 Oct 2023Deal completed8.80%19.35m
Data delayed at least 15 minutes, as of May 08 2024 20:58 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Fonar Corp140.58m16.69m157.96m561.009.840.70235.541.121.741.7414.6024.420.512420.351.44182,570.608.338.738.649.6045.6748.3316.2516.399.15--0.0055--1.083.89-24.71-15.058.48--
Akso Health Group - ADR3.02m-23.43m161.07m12.00------53.27-0.7466-0.24610.0963--0.11661.910.3202183,560.00-89.84-17.36-224.28-23.997.56---770.59-256.641.36-24.020.6531--119.69-34.25-221.68------
TELA Bio Inc80.23m-64.05m166.49m227.00--6.38--2.08-2.06-2.062.560.77080.80131.477.15257,502.20-63.97-52.00-80.09-60.9568.6265.32-79.83-107.653.45-8.440.6821--41.1347.85-5.35---17.12--
Delcath Systems Inc2.83m-65.44m199.38m76.00--8.24--70.34-2.98-2.980.12730.69310.07310.23876.8027,171.05-168.85-116.57-377.02-243.2169.2571.02-2,308.86-1,235.372.06-26.530.3915---24.05-9.53-30.60---5.26--
Electromed Inc70.95m5.40m206.82m170.0038.933.7332.382.910.44980.44985.914.691.172.952.27304,076.508.917.8610.399.1476.5176.257.627.385.25--0.000.0015.3811.1737.3511.0024.58--
Hamilton Thorne Ltd92.25m-833.01k211.98m----2.3833.212.30-0.0059-0.00590.62230.58320.68622.508.78---0.61961.50-0.73441.7850.3550.84-0.9032.181.191.430.3019--15.5518.14-131.77--26.56--
Clearpoint Neuro Inc32.88m-30.32m218.85m107.00--6.86--6.66-0.8979-0.89790.97360.85890.48811.208.15223,878.50-45.01-34.75-52.63-39.6756.8364.75-92.21-76.913.80--0.3197--16.5626.64-34.40--75.30--
Inogen Inc433.27m-140.62m235.94m834.00--0.8314--0.5446-4.42-4.4213.628.780.86346.766.01378,489.20-28.02-8.23-34.53-9.5340.1444.54-32.46-10.312.56--0.00---16.32-2.49-22.30--26.34--
InfuSystem Holdings Inc172.65m1.20m236.71m499.00204.643.2912.841.370.03960.03965.862.471.2411.176.85252,074.100.86214.601.015.6950.1756.430.69334.071.541.880.35750.0014.4413.384,744.44--6.01--
Accuray Inc590.98m-29.49m238.21m1.02k--4.22--0.4031-0.2197-0.21974.420.41430.91781.865.72420,462.90-4.58-1.45-7.84-2.4833.0637.86-4.99-1.620.778-0.47440.8086--4.122.03-73.56--13.92--
CVRx Inc57.77m-71.39m240.10m200.00--2.64--4.16-2.48-2.482.013.070.36780.67815.64210,430.00-45.45---48.95--84.45---123.58--10.87-21.110.3064--74.89--0.5528------
Orchestra Biomed Holdings Inc3.79m-67.42m244.62m56.00--2.62--64.57-1.49-1.490.08321.900.02890.881528.3149,285.71-51.49---61.01--93.26---1,779.71--7.94--0.00---21.88---37.91------
Profound Medical Corp9.88m-39.21m250.78m131.00--5.10--25.38-1.85-1.850.46642.000.13290.37741.1475,413.65-52.74-38.41-58.43-41.9560.8750.32-396.85-387.155.48-353.280.203--7.7529.090.3488------
Stereotaxis Inc36.75m-30.27m253.64m122.00--11.14--6.90-0.2737-0.27370.33180.27080.56171.466.01219,434.40-43.46-25.02-61.11-34.1255.5167.57-77.37-41.901.88--0.00---4.89-1.82-12.33--6.63--
Outset Medical Inc178.95m-237.18m268.96m480.00--1.55--1.50-3.49-3.492.642.440.36522.014.27271,616.70-48.41-41.40-56.97-47.2922.245.71-132.54-159.054.37-67.800.5143--13.00130.43-6.04--14.27--
Data as of May 08 2024. Currency figures normalised to Hamilton Thorne Ltd's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.